This inventor holds 37 USPTO granted patents and 16 published patent applications, plus 7 CIPO patents and 10 EPO patents, primarily in Fc Variants. Top assignees: Xencor, Inc., Janssen Biotech, Inc.. Active years: 2008-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Radnor, PA (US) (2015)
- Spring House, PA (US) (2017)
- Phoenixville, PA (US) (2018)
- Monrovia, CA (US) (2008 - 2020)
- Valley Forge, PA (US) (2021)
- Santa Monica, CA (US) (2023)
Company Filing History:
Years Active: 2008-2023
Areas of Expertise:
Title: Omid Vafa: Innovator in Fc Variant Technologies
Introduction
Omid Vafa, based in Monrovia, CA, is a prominent inventor known for his influential contributions in the field of engineering, particularly in the development of Fc variant technologies. With a remarkable portfolio encompassing 33 patents under his name, he has established himself as a leading innovator in the industry.
Latest Patents
Among his recent patents, two stand out:
1. **Optimized Fc Variants** - This invention focuses on Fc variants that exhibit decreased affinity for FcγRIIb. The technologies involve methods for generating these variants, as well as Fc polypeptides that contain the optimized Fc variants, and various methods for utilizing them effectively.
2. **Fc Variants with Increased Affinity for FcγRIIc** - This patent details Fc variants that possess enhanced affinity for FcγRIIc. It includes methods for their generation, corresponding Fc polypeptides, and applications for these optimized Fc variants.
Career Highlights
Omid Vafa is associated with Xencor, Inc., a leading biopharmaceutical company dedicated to developing engineered monoclonal antibodies and other protein therapeutics. His innovative patents have significantly advanced the company's research and development initiatives, driving breakthroughs in targeted therapies.
Collaborations
Throughout his career, Omid has collaborated with various esteemed colleagues, including Gregory Alan Lazar and Wei Dang. These partnerships have fostered a vibrant exchange of ideas and technical knowledge, enhancing the innovative capabilities of their projects.
Conclusion
Omid Vafa exemplifies the spirit of innovation in the realm of biotechnology. Through his patents and collaborative efforts, he continues to contribute significantly to advancements in Fc variants, shaping the future of therapeutic development. His work at Xencor, Inc. ensures that his contributions will have a lasting impact on medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile